TANILLYA PARTRIDGE: Open Payments
NPI 1851645550 · YANCEYILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,457 in 55 payments from 11 companies in 2025. Trend: 2023 $848 · 2024 $1,622 · 2025 $1,457
Food & beverage: $1,457
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $465 |
| Janssen Pharmaceuticals, Inc | 8 | $289 |
| Teva Pharmaceuticals USA, Inc. | 12 | $274 |
| Lundbeck LLC | 6 | $143 |
| Vanda Pharmaceuticals Inc. | 3 | $78 |
| Neurocrine BioSciences, Inc. | 3 | $59 |
| ABBVIE INC. | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Lilly USA, LLC | 1 | $22 |
| Alkermes, Inc. | 1 | $18 |
Products named: CAPLYTA, INVEGA SUSTENNA, AUSTEDO XR, REXULTI, INGREZZA, FANAPT, VRAYLAR, ABILIFY ASIMTUFII.
Industry payments across NC — which companies pay providers there.
